Unless otherwise indicated, this information has been self-reported and has not been
verified by the Board of Medicine.
Publications
(up to ten in the last five years)
Last Updated 7/15/2022
Hepatology
Volume: 52(3)
Date: 09 2010
www.ncbi.nlm.nih.gov/pmc/articles/PMC3032356/?tool=pubmed
Expansion of hepatic tumor progenitor cells in Pten-null mice requires liver injury and is reversed by loss of AKT2
Gastroenterology
Volume: 139(6)
Date: 12 2010
www.ncbi.nlm.nih.gov/pmc/articles/PMC2997180/?tool=pubmed
c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma.
Hepatology
Volume: 54(3)
Date: 09 2011
onlinelibrary.wiley.com/doi/10.1002/hep.24450/pdf
Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics
BMC Cancer
Volume: 11
Date: 09 2011
www.biomedcentral.com/1471-2407/11/396
Isolation of CD133+ liver stem cells for clonal expansion.
Journal of Visual Experiments
Volume: 56
Date: 10 2011
www.jove.com/video/3183/isolation-of-cd133-liver-stem-cells-for-clonal-expansion?id=3183
Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model.
Hepatology
Volume: 55(1)
Date: 01 2012
onlinelibrary.wiley.com/doi/10.1002/hep.24652/pdf
Stem cells in liver diseases and cancer: recent advances on the path to new therapies
Hepatology
Volume: 55(1)
Date: 01 2012
onlinelibrary.wiley.com/doi/10.1002/hep.24762/full
miR-200b restoration and DNA methyltransferase inhibitor
Oncogenesis
Date: 05 2012
